Executive Summary: Key Legal and Evidentiary Issues

• Dispute involved competing claims over the lawful board of directors of a publicly traded Ontario corporation listed on NASDAQ.

• Improperly convened board and shareholder meetings led to conflicting removal attempts of directors, deemed null by the court.

• Evidence revealed potential oppressive conduct and breach of fiduciary duties by the founder and director, Fan Zhou.

• The court found prima facie grounds under s. 161(2)(b) of the OBCA to warrant appointment of an inspector.

• An interlocutory injunction was granted to restrain Zhou from managing the company pending investigation.

• Voting control through special Class B shares held by a related party was frozen to maintain board stability during proceedings.

Background and conflict over board control

The case involves a high-stakes governance dispute within Visionary Holdings Inc. (VHI), a publicly traded Ontario corporation listed on NASDAQ. The plaintiffs included Fan Zhou, the company’s founder and a director, as well as her closely held entities—3888 Investment Group Limited and Visionary Holdings itself. The defendants were five members of VHI’s board of directors, who challenged Zhou’s actions and sought urgent relief to prevent ongoing harm to the company.

Tensions escalated following two competing attempts to restructure the board. On March 26, 2025, several directors held an “urgent” meeting to remove Zhou and another director. Zhou responded by orchestrating a shareholder meeting on April 4, 2025, to remove the defendants. Both meetings were found to have violated procedural requirements under VHI’s by-laws and the Ontario Business Corporations Act (OBCA), and were declared void.

Allegations of oppression and misconduct

The central issue was who constituted the lawful board and whether Zhou had exercised her corporate powers oppressively or in breach of fiduciary duties. The court reviewed extensive evidence of questionable conduct. Notably, Zhou had failed to inform the board of a significant lawsuit (the “Zhang Action”) against VHI, retained counsel to represent all parties unilaterally, and signed $1.5 million in promissory notes on VHI’s behalf without board approval.

Additionally, Zhou was accused of issuing a misleading press release about a fictitious $1 billion investment from Alfardan Group, which prompted an official retraction demand from Alfardan’s legal counsel. Other concerns included Zhou’s private share transaction with an investor who transferred funds to Zhou’s personal U.S. company, raising questions of fraud and misrepresentation.

Court’s analysis and orders

Justice Steele confirmed that the board of directors as it existed on March 25, 2025, remained the lawful board until further court order. The court also held that the defendants had established a prima facie case under s. 161(2)(b) of the OBCA, warranting an investigation into potentially oppressive or dishonest conduct.

In response, the court appointed an independent inspector and granted a suite of interim relief. Zhou was restrained from participating in the management of VHI. Similarly, 3888 Investment Group—controlled by Zhou’s daughter and holder of super-voting Class B shares—was barred from using those votes to alter board composition during the investigation. The injunctions aimed to preserve the company’s integrity and regulatory standing, particularly amid the risk of NASDAQ delisting.

Outcome

The court ordered the appointment of an inspector, restrained Zhou from acting as a director or officer, and preserved the board composition pending further orders. Both the March 26 and April 4 meetings were declared nullities. The decision underscores the seriousness with which courts address alleged corporate misconduct and the robust interim remedies available under the OBCA to protect the interests of public companies and minority shareholders.